APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sanger Sequencing Service

DNA sequencing refers to the methods and technologies that used to determine the orders of nucleotide bases in a DNA molecule, namely adenine (A), guanine (G), cytosine (C) and thymine (T). DNA sequencing enables us to perform a thorough analysis of DNA because it provides us with the most basic information of all: the sequence of nucleotides. The knowledge of DNA sequences has formed the basis of basic biological researches and clinical genetic diagnosis. There are also numerous applied technology fields such as biotechnology, forensic science and biological systematics that are heavily dependent on the information generated through DNA sequencing. The rapid speed of sequencing attained with modern DNA sequencing technology has been instrumental in the sequencing of the human genome, in the Human Genome Project. Related projects, often by scientific collaboration across continents, have generated the complete DNA sequences the genomes of many animals, plants, and microorganisms. The Sanger method, also referred to as dideoxynucleotide sequencing or chain termination sequencing, is based on the use of dideoxynucleotide (ddNTP) in addition to the normal nucleotides (dNTP) found in DNA. Dideoxynucleotide are essentially the same as nucleotides except they contain a hydrogen group on the 3’ carbon instead of a hydroxyl group (OH). These modified nucleotides, when integrated into a DNA sequence, prevent the addition of further nucleotides thus stop the elongation of the DNA chain. This occurs because a phosphodiester bond cannot form between the dideoxynucleotide and the next incoming nucleotide, and thus the DNA chain is terminated.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

DNA sequencing refers to the methods and technologies that used to determine the orders of nucleotide bases in a DNA molecule, namely adenine (A), guanine (G), cytosine (C) and thymine (T). DNA sequencing enables us to perform a thorough analysis of DNA because it provides us with the most basic information of all: the sequence of nucleotides. The knowledge of DNA sequences has formed the basis of basic biological researches and clinical genetic diagnosis. There are also numerous applied technology fields such as biotechnology, forensic science and biological systematics that are heavily dependent on the information generated through DNA sequencing. The rapid speed of sequencing attained with modern DNA sequencing technology has been instrumental in the sequencing of the human genome, in the Human Genome Project. Related projects, often by scientific collaboration across continents, have generated the complete DNA sequences the genomes of many animals, plants, and microorganisms. The Sanger method, also referred to as dideoxynucleotide sequencing or chain termination sequencing, is based on the use of dideoxynucleotide (ddNTP) in addition to the normal nucleotides (dNTP) found in DNA. Dideoxynucleotide are essentially the same as nucleotides except they contain a hydrogen group on the 3’ carbon instead of a hydroxyl group (OH). These modified nucleotides, when integrated into a DNA sequence, prevent the addition of further nucleotides thus stop the elongation of the DNA chain. This occurs because a phosphodiester bond cannot form between the dideoxynucleotide and the next incoming nucleotide, and thus the DNA chain is terminated.

Selected research

Market Outlook & Growth Opportunities

Global Sanger Sequencing Service Market Outlook and Growth Opportunities 2026

1 January 2026194 pages

Choose your research edition.

Industry ResearchSanger Sequencing Service Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Sanger Sequencing Service Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Sanger Sequencing Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sanger Sequencing Service Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Sanger Sequencing Service Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

DNA sequencing refers to the methods and technologies that used to determine the orders of nucleotide bases in a DNA molecule, namely adenine (A), guanine (G), cytosine (C) and thymine (T). DNA sequencing enables us to perform a thorough analysis of DNA because it provides us with the most basic information of all: the sequence of nucleotides. The knowledge of DNA sequences has formed the basis of basic biological researches and clinical genetic diagnosis. There are also numerous applied technology fields such as biotechnology, forensic science and biological systematics that are heavily dependent on the information generated through DNA sequencing. The rapid speed of sequencing attained with modern DNA sequencing technology has been instrumental in the sequencing of the human genome, in the Human Genome Project. Related projects, often by scientific collaboration across continents, have generated the complete DNA sequences the genomes of many animals, plants, and microorganisms. The Sanger method, also referred to as dideoxynucleotide sequencing or chain termination sequencing, is based on the use of dideoxynucleotide (ddNTP) in addition to the normal nucleotides (dNTP) found in DNA. Dideoxynucleotide are essentially the same as nucleotides except they contain a hydrogen group on the 3’ carbon instead of a hydroxyl group (OH). These modified nucleotides, when integrated into a DNA sequence, prevent the addition of further nucleotides thus stop the elongation of the DNA chain. This occurs because a phosphodiester bond cannot form between the dideoxynucleotide and the next incoming nucleotide, and thus the DNA chain is terminated.

Global Sanger Sequencing Service key players include Eurofins, Thermofisher, Genewiz, Nucleics, SciGenom Labs, etc. Global top five manufacturers hold a share about 70%. United States is the largest market, with a share about 25%, followed by Europe and China, both with a share about 20 percent. In terms of product, PCR amplicons is the largest segment, with a share about 60%. And in terms of application, the largest application is Institutions, followed by Bioscience Companies, Hospitals.

This report provides an overview of the global Sanger Sequencing Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Sanger Sequencing Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Sanger Sequencing Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Sanger Sequencing Service market.

Sanger Sequencing Service Segment by Company

Source BioScience

GenScript

Thermofisher

Nucleics

GenHunter Corporation

LGC Limited

SciGenom Labs

Fasteris SA

CeMIA SA

Microsynth AG

QuintaraBio

Eurofins

Genewiz

Sanger Sequencing Service Segment by Type

Plasmid DNA

PCR Amplicons

Others

Sanger Sequencing Service Segment by Application

Bioscience Companies

Hospitals

Institutions

Sanger Sequencing Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Sanger Sequencing Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Sanger Sequencing Service key companies, revenue, market share, and recent developments.

3. To split the Sanger Sequencing Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Sanger Sequencing Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Sanger Sequencing Service significant trends, drivers, influence factors in global and regions.

6. To analyze Sanger Sequencing Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sanger Sequencing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sanger Sequencing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sanger Sequencing Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Sanger Sequencing Service industry.

Chapter 3: Detailed analysis of Sanger Sequencing Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Sanger Sequencing Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Sanger Sequencing Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Sanger Sequencing Service Industry Trends Table 2. Sanger Sequencing Service Industry Drivers Table 3. Sanger Sequencing Service Industry Opportunities and Challenges Table 4. Sanger Sequencing Service Industry Restraints Table 5. Global Sanger Sequencing Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Sanger Sequencing Service Revenue Share by Company (2021-2026) Table 7. Global Sanger Sequencing Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Sanger Sequencing Service Key Company Manufacturing Base & Headquarters Table 9. Global Sanger Sequencing Service Company, Product Type & Application Table 10. Global Sanger Sequencing Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Sanger Sequencing Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Plasmid DNA Table 15. Significant Companies of PCR Amplicons Table 16. Significant Companies of Others Table 17. Global Sanger Sequencing Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Sanger Sequencing Service Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Sanger Sequencing Service Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Sanger Sequencing Service Sales Value Share by Type (2021-2026) Table 21. Global Sanger Sequencing Service Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Bioscience Companies Table 23. Significant Companies of Hospitals Table 24. Significant Companies of Institutions Table 25. Global Sanger Sequencing Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Sanger Sequencing Service Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Sanger Sequencing Service Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Sanger Sequencing Service Sales Value Share by Application (2021-2026) Table 29. Global Sanger Sequencing Service Sales Value Share by Application (2027-2032) Table 30. Global Sanger Sequencing Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Sanger Sequencing Service Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Sanger Sequencing Service Sales Value Share by Region (2021-2026) Table 33. Global Sanger Sequencing Service Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Sanger Sequencing Service Sales Value Share by Region (2027-2032) Table 35. Global Sanger Sequencing Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Sanger Sequencing Service Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Sanger Sequencing Service Sales Value Market Share by Country (2021-2026) Table 38. Global Sanger Sequencing Service Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Sanger Sequencing Service Sales Value Market Share by Country (2027-2032) Table 40. Source BioScience Company Information Table 41. Source BioScience Business Overview Table 42. Source BioScience Sanger Sequencing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Source BioScience Sanger Sequencing Service Product Portfolio Table 44. Source BioScience Recent Development Table 45. GenScript Company Information Table 46. GenScript Business Overview Table 47. GenScript Sanger Sequencing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. GenScript Sanger Sequencing Service Product Portfolio Table 49. GenScript Recent Development Table 50. Thermofisher Company Information Table 51. Thermofisher Business Overview Table 52. Thermofisher Sanger Sequencing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Thermofisher Sanger Sequencing Service Product Portfolio Table 54. Thermofisher Recent Development Table 55. Nucleics Company Information Table 56. Nucleics Business Overview Table 57. Nucleics Sanger Sequencing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Nucleics Sanger Sequencing Service Product Portfolio Table 59. Nucleics Recent Development Table 60. GenHunter Corporation Company Information Table 61. GenHunter Corporation Business Overview Table 62. GenHunter Corporation Sanger Sequencing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. GenHunter Corporation Sanger Sequencing Service Product Portfolio Table 64. GenHunter Corporation Recent Development Table 65. LGC Limited Company Information Table 66. LGC Limited Business Overview Table 67. LGC Limited Sanger Sequencing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. LGC Limited Sanger Sequencing Service Product Portfolio Table 69. LGC Limited Recent Development Table 70. SciGenom Labs Company Information Table 71. SciGenom Labs Business Overview Table 72. SciGenom Labs Sanger Sequencing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. SciGenom Labs Sanger Sequencing Service Product Portfolio Table 74. SciGenom Labs Recent Development Table 75. Fasteris SA Company Information Table 76. Fasteris SA Business Overview Table 77. Fasteris SA Sanger Sequencing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Fasteris SA Sanger Sequencing Service Product Portfolio Table 79. Fasteris SA Recent Development Table 80. CeMIA SA Company Information Table 81. CeMIA SA Business Overview Table 82. CeMIA SA Sanger Sequencing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. CeMIA SA Sanger Sequencing Service Product Portfolio Table 84. CeMIA SA Recent Development Table 85. Microsynth AG Company Information Table 86. Microsynth AG Business Overview Table 87. Microsynth AG Sanger Sequencing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Microsynth AG Sanger Sequencing Service Product Portfolio Table 89. Microsynth AG Recent Development Table 90. QuintaraBio Company Information Table 91. QuintaraBio Business Overview Table 92. QuintaraBio Sanger Sequencing Service Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 93. QuintaraBio Sanger Sequencing Service Product Portfolio Table 94. QuintaraBio Recent Development Table 95. Eurofins Company Information Table 96. Eurofins Business Overview Table 97. Eurofins Sanger Sequencing Service Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 98. Eurofins Sanger Sequencing Service Product Portfolio Table 99. Eurofins Recent Development Table 100. Genewiz Company Information Table 101. Genewiz Business Overview Table 102. Genewiz Sanger Sequencing Service Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 103. Genewiz Sanger Sequencing Service Product Portfolio Table 104. Genewiz Recent Development Table 105. Research Programs/Design for This Report Table 106. Authors List of This Report Table 107. Secondary Sources Table 108. Primary Sources List of Figures Figure 1. Sanger Sequencing Service Product Image Figure 2. Global Sanger Sequencing Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sanger Sequencing Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Sanger Sequencing Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Plasmid DNA Image Figure 8. PCR Amplicons Image Figure 9. Others Image Figure 10. Global Sanger Sequencing Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Sanger Sequencing Service Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Sanger Sequencing Service Sales Value Share by Type (2021-2032) Figure 13. Bioscience Companies Image Figure 14. Hospitals Image Figure 15. Institutions Image Figure 16. Global Sanger Sequencing Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Sanger Sequencing Service Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Sanger Sequencing Service Sales Value Share by Application (2021-2032) Figure 19. Global Sanger Sequencing Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Sanger Sequencing Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Sanger Sequencing Service Sales Value (2021-2032) & (US$ Million) Figure 22. North America Sanger Sequencing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Sanger Sequencing Service Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Sanger Sequencing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Sanger Sequencing Service Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Sanger Sequencing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Sanger Sequencing Service Sales Value (2021-2032) & (US$ Million) Figure 28. South America Sanger Sequencing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Sanger Sequencing Service Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Sanger Sequencing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Sanger Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Sanger Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Sanger Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Sanger Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Sanger Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Sanger Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Sanger Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Sanger Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Sanger Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Sanger Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Sanger Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Sanger Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Sanger Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Sanger Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Sanger Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Sanger Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Sanger Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Sanger Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Sanger Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Sanger Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Sanger Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Sanger Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Sanger Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Sanger Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Sanger Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Sanger Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Sanger Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Sanger Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Sanger Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Sanger Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Sanger Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Sanger Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Sanger Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Sanger Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Sanger Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Sanger Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Sanger Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Sanger Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Sanger Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Sanger Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Sanger Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Sanger Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Sanger Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Sanger Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Sanger Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Sanger Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Sanger Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Sanger Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Sanger Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Sanger Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Sanger Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Sanger Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Sanger Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Sanger Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Sanger Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Sanger Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Sanger Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Sanger Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Sanger Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Sanger Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Sanger Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Sanger Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Sanger Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Sanger Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Sanger Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Sanger Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Sanger Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Sanger Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Sanger Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Sanger Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Sanger Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Sanger Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Sanger Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Sanger Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Sanger Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Sanger Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Sanger Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Sanger Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Sanger Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Sanger Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Sanger Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Sanger Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Sanger Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Sanger Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Plasmid DNA
  • PCR Amplicons
  • Others
Applications
  • Bioscience Companies
  • Hospitals
  • Institutions
Companies covered
  • Source BioScience
  • GenScript
  • Thermofisher
  • Nucleics
  • GenHunter Corporation
  • LGC Limited
  • SciGenom Labs
  • Fasteris SA
  • CeMIA SA
  • Microsynth AG
  • QuintaraBio
  • Eurofins
  • Genewiz

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Sanger Sequencing Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Sanger Sequencing Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Sanger Sequencing Service Market Dynamics
  1. 2.1 Sanger Sequencing Service Industry Trends
  2. 2.2 Sanger Sequencing Service Industry Drivers
  3. 2.3 Sanger Sequencing Service Industry Opportunities and Challenges
  4. 2.4 Sanger Sequencing Service Industry Restraints
3 Sanger Sequencing Service Market by Company
  1. 3.1 Global Sanger Sequencing Service Company Revenue Ranking in 2025
  2. 3.2 Global Sanger Sequencing Service Revenue by Company (2021-2026)
  3. 3.3 Global Sanger Sequencing Service Company Ranking (2024-2026)
  4. 3.4 Global Sanger Sequencing Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Sanger Sequencing Service Company Product Type and Application
  6. 3.6 Global Sanger Sequencing Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Sanger Sequencing Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Sanger Sequencing Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Sanger Sequencing Service Market by Type
  1. 4.1 Sanger Sequencing Service Type Introduction
  2. 4.1.1 Plasmid DNA
  3. 4.1.2 PCR Amplicons
  4. 4.1.3 Others
  5. 4.2 Global Sanger Sequencing Service Sales Value by Type
  6. 4.2.1 Global Sanger Sequencing Service Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Sanger Sequencing Service Sales Value by Type (2021-2032)
  8. 4.2.3 Global Sanger Sequencing Service Sales Value Share by Type (2021-2032)
5 Sanger Sequencing Service Market by Application
  1. 5.1 Sanger Sequencing Service Application Introduction
  2. 5.1.1 Bioscience Companies
  3. 5.1.2 Hospitals
  4. 5.1.3 Institutions
  5. 5.2 Global Sanger Sequencing Service Sales Value by Application
  6. 5.2.1 Global Sanger Sequencing Service Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Sanger Sequencing Service Sales Value by Application (2021-2032)
  8. 5.2.3 Global Sanger Sequencing Service Sales Value Share by Application (2021-2032)
6 Sanger Sequencing Service Regional Value Analysis
  1. 6.1 Global Sanger Sequencing Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Sanger Sequencing Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Sanger Sequencing Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Sanger Sequencing Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Sanger Sequencing Service Sales Value (2021-2032)
  7. 6.3.2 North America Sanger Sequencing Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Sanger Sequencing Service Sales Value (2021-2032)
  10. 6.4.2 Europe Sanger Sequencing Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Sanger Sequencing Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Sanger Sequencing Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Sanger Sequencing Service Sales Value (2021-2032)
  16. 6.6.2 South America Sanger Sequencing Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Sanger Sequencing Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Sanger Sequencing Service Sales Value Share by Country, 2025 VS 2032
7 Sanger Sequencing Service Country-level Value Analysis
  1. 7.1 Global Sanger Sequencing Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Sanger Sequencing Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Sanger Sequencing Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Sanger Sequencing Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Sanger Sequencing Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Sanger Sequencing Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Sanger Sequencing Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Sanger Sequencing Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Sanger Sequencing Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Sanger Sequencing Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Sanger Sequencing Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Sanger Sequencing Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Sanger Sequencing Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Sanger Sequencing Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Sanger Sequencing Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Sanger Sequencing Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Sanger Sequencing Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Sanger Sequencing Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Sanger Sequencing Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Sanger Sequencing Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Sanger Sequencing Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Sanger Sequencing Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Sanger Sequencing Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Sanger Sequencing Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Sanger Sequencing Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Sanger Sequencing Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Sanger Sequencing Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Sanger Sequencing Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Sanger Sequencing Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Sanger Sequencing Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Sanger Sequencing Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Sanger Sequencing Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Sanger Sequencing Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Sanger Sequencing Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Sanger Sequencing Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Sanger Sequencing Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Sanger Sequencing Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Sanger Sequencing Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Sanger Sequencing Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Sanger Sequencing Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Sanger Sequencing Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Sanger Sequencing Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Sanger Sequencing Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Sanger Sequencing Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Sanger Sequencing Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Sanger Sequencing Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Sanger Sequencing Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Sanger Sequencing Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Sanger Sequencing Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Sanger Sequencing Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Sanger Sequencing Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Sanger Sequencing Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Sanger Sequencing Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Sanger Sequencing Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Sanger Sequencing Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Sanger Sequencing Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Sanger Sequencing Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Sanger Sequencing Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Sanger Sequencing Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Sanger Sequencing Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Sanger Sequencing Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Sanger Sequencing Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Sanger Sequencing Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Sanger Sequencing Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Sanger Sequencing Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Sanger Sequencing Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Sanger Sequencing Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Sanger Sequencing Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Sanger Sequencing Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Sanger Sequencing Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Sanger Sequencing Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Sanger Sequencing Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Sanger Sequencing Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Sanger Sequencing Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Sanger Sequencing Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Sanger Sequencing Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Sanger Sequencing Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Sanger Sequencing Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Sanger Sequencing Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Sanger Sequencing Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Sanger Sequencing Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Sanger Sequencing Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Sanger Sequencing Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Sanger Sequencing Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Sanger Sequencing Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Sanger Sequencing Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Sanger Sequencing Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Sanger Sequencing Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Source BioScience
  2. 8.1.1 Source BioScience Company Information
  3. 8.1.2 Source BioScience Business Overview
  4. 8.1.3 Source BioScience Sanger Sequencing Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Source BioScience Sanger Sequencing Service Product Portfolio
  6. 8.1.5 Source BioScience Recent Developments
  7. 8.2 GenScript
  8. 8.2.1 GenScript Company Information
  9. 8.2.2 GenScript Business Overview
  10. 8.2.3 GenScript Sanger Sequencing Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 GenScript Sanger Sequencing Service Product Portfolio
  12. 8.2.5 GenScript Recent Developments
  13. 8.3 Thermofisher
  14. 8.3.1 Thermofisher Company Information
  15. 8.3.2 Thermofisher Business Overview
  16. 8.3.3 Thermofisher Sanger Sequencing Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Thermofisher Sanger Sequencing Service Product Portfolio
  18. 8.3.5 Thermofisher Recent Developments
  19. 8.4 Nucleics
  20. 8.4.1 Nucleics Company Information
  21. 8.4.2 Nucleics Business Overview
  22. 8.4.3 Nucleics Sanger Sequencing Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Nucleics Sanger Sequencing Service Product Portfolio
  24. 8.4.5 Nucleics Recent Developments
  25. 8.5 GenHunter Corporation
  26. 8.5.1 GenHunter Corporation Company Information
  27. 8.5.2 GenHunter Corporation Business Overview
  28. 8.5.3 GenHunter Corporation Sanger Sequencing Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 GenHunter Corporation Sanger Sequencing Service Product Portfolio
  30. 8.5.5 GenHunter Corporation Recent Developments
  31. 8.6 LGC Limited
  32. 8.6.1 LGC Limited Company Information
  33. 8.6.2 LGC Limited Business Overview
  34. 8.6.3 LGC Limited Sanger Sequencing Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 LGC Limited Sanger Sequencing Service Product Portfolio
  36. 8.6.5 LGC Limited Recent Developments
  37. 8.7 SciGenom Labs
  38. 8.7.1 SciGenom Labs Company Information
  39. 8.7.2 SciGenom Labs Business Overview
  40. 8.7.3 SciGenom Labs Sanger Sequencing Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 SciGenom Labs Sanger Sequencing Service Product Portfolio
  42. 8.7.5 SciGenom Labs Recent Developments
  43. 8.8 Fasteris SA
  44. 8.8.1 Fasteris SA Company Information
  45. 8.8.2 Fasteris SA Business Overview
  46. 8.8.3 Fasteris SA Sanger Sequencing Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Fasteris SA Sanger Sequencing Service Product Portfolio
  48. 8.8.5 Fasteris SA Recent Developments
  49. 8.9 CeMIA SA
  50. 8.9.1 CeMIA SA Company Information
  51. 8.9.2 CeMIA SA Business Overview
  52. 8.9.3 CeMIA SA Sanger Sequencing Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 CeMIA SA Sanger Sequencing Service Product Portfolio
  54. 8.9.5 CeMIA SA Recent Developments
  55. 8.10 Microsynth AG
  56. 8.10.1 Microsynth AG Company Information
  57. 8.10.2 Microsynth AG Business Overview
  58. 8.10.3 Microsynth AG Sanger Sequencing Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Microsynth AG Sanger Sequencing Service Product Portfolio
  60. 8.10.5 Microsynth AG Recent Developments
  61. 8.11 QuintaraBio
  62. 8.11.1 QuintaraBio Company Information
  63. 8.11.2 QuintaraBio Business Overview
  64. 8.11.3 QuintaraBio Sanger Sequencing Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 QuintaraBio Sanger Sequencing Service Product Portfolio
  66. 8.11.5 QuintaraBio Recent Developments
  67. 8.12 Eurofins
  68. 8.12.1 Eurofins Company Information
  69. 8.12.2 Eurofins Business Overview
  70. 8.12.3 Eurofins Sanger Sequencing Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Eurofins Sanger Sequencing Service Product Portfolio
  72. 8.12.5 Eurofins Recent Developments
  73. 8.13 Genewiz
  74. 8.13.1 Genewiz Company Information
  75. 8.13.2 Genewiz Business Overview
  76. 8.13.3 Genewiz Sanger Sequencing Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Genewiz Sanger Sequencing Service Product Portfolio
  78. 8.13.5 Genewiz Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst